James McNeill appointed by inTechnology Distribution
James McNeill as their Regional Director for Healthcare & Critical Communications across the Asia Pacific Region.
"We are very pleased to have James join our team," said Mark Winter, CEO of inTechnology Distribution.
"His appointment is a key part of our strategy to continue to grow our healthcare & clinical communications business in the Asia Pacific Region. James's experience and knowledge will be invaluable as we continue to expand our presence in the region," Winter adds.
"Working in different areas within the health sector allowed me to see that every day there are patients, healthcare professionals and organisations dealing with the same communication issues and challenges. As well as understanding how effective critical communications are within every industry," says McNeill.
"My role with inTechnology puts me in a position to help more clients and resellers in a more impactful way rather than just one partner or client at a time."
McNeill's role will see him regularly travel to engage, collaborate, and partner with resellers and customers across Asia Pacific to help them deliver their strategic communication priorities.
"We have an extensive healthcare centric product portfolio along with a solid partner and customer base, and we are committed to investing in innovation across the healthcare sector," inTechnology Chief Operating Officer Brandon Winter says.
"Clinical Communication is now a critical element across the healthcare sector, and we are very proud to have a senior health executive of James's calibre to lead the direction of our work with the health sector."
McNeill will be the driving force behind the re-launch of the Spok Partner Program to the APAC channel. Through the partner program, inTechnology Distribution and Spok will offer various tools such as business planning, technical support, training, marketing, and co-development to support partners in scaling their respective businesses. The Partner Ecosystem will become one of the core pillars of James's strategy for the Asia Pacific market.
